|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_ocn994302500 |
| 003 |
OCoLC |
| 005 |
20231120010209.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170724s2017 enk ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d IDEBK
|d EBLCP
|d STF
|d UAB
|d N$T
|d OCLCQ
|d MERER
|d OCLCQ
|d TXM
|d OCLCQ
|d OCLCF
|d UPM
|d OCLCQ
|d CASUM
|d OCLCQ
|d OCLCA
|d U3G
|d OCLCO
|d D6H
|d COS
|d COF
|d UWW
|d YDX
|d U3W
|d ITD
|d OCLCO
|d AU@
|d OCLCO
|d WYU
|d OCLCO
|d OCLCQ
|d OCLCO
|d S2H
|d OCLCO
|d LVT
|d OCLCA
|d OCLCO
|d OCLCQ
|d SFB
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 994819241
|a 1229877054
|
| 020 |
|
|
|a 9780128122792
|q (electronic bk.)
|
| 020 |
|
|
|a 012812279X
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128122594
|q (print)
|
| 020 |
|
|
|a 0128122595
|
| 020 |
|
|
|a 9780128122594
|
| 035 |
|
|
|a (OCoLC)994302500
|z (OCoLC)994819241
|z (OCoLC)1229877054
|
| 050 |
|
4 |
|a RC523
|
| 060 |
|
4 |
|a 2017 H-164
|
| 060 |
|
4 |
|a WT 155
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.8/311061
|2 23
|
| 100 |
1 |
|
|a Friel, Howard,
|d 1955-
|e author.
|
| 245 |
1 |
2 |
|a A paradigm shift to prevent and treat Alzheimer's disease :
|b from monotargeting pharmaceuticals to pleiotropic plant polyphenols /
|c Howard Friel and Sally Frautschy.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press, an imprint of Elsevier,
|c 2017.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed July 27, 2017).
|
| 505 |
0 |
|
|6 880-01
|a Monotargeting versus multitargeting -- The Pleiotropic pharmacology of plant polyphenols -- Primary prevention of Alzheimer's disease -- Secondary prevention of Alzheimer's disease -- Treatment mechanisms in mild to moderate Alzheimer's disease -- Pleiotropic theory -- Dose-adherence and intent-to-treat.
|
| 650 |
|
0 |
|a Alzheimer's disease
|x Chemotherapy.
|
| 650 |
|
0 |
|a Alzheimer's disease
|x Prevention.
|
| 650 |
1 |
2 |
|a Alzheimer Disease
|x drug therapy
|0 (DNLM)D000544Q000188
|
| 650 |
1 |
2 |
|a Alzheimer Disease
|x prevention & control
|0 (DNLM)D000544Q000517
|
| 650 |
2 |
2 |
|a Molecular Targeted Therapy
|0 (DNLM)D058990
|
| 650 |
2 |
2 |
|a Plant Extracts
|x therapeutic use
|0 (DNLM)D010936Q000627
|
| 650 |
2 |
2 |
|a Polyphenols
|x therapeutic use
|0 (DNLM)D059808Q000627
|
| 650 |
|
6 |
|a Maladie d'Alzheimer
|x Chimioth�erapie.
|0 (CaQQLa)201-0330307
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Alzheimer's disease
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00806536
|
| 650 |
|
7 |
|a Alzheimer's disease
|x Prevention
|2 fast
|0 (OCoLC)fst00806584
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a Frautschy, Sally A.,
|e author.
|
| 776 |
0 |
8 |
|i Print version:
|a Friel, Howard, 1955-
|t Paradigm shift to prevent and treat Alzheimer's disease.
|d London, United Kingdom : Academic Press, an imprint of Elsevier, 2017
|z 9780128122594
|z 0128122595
|w (OCoLC)974698869
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128122594
|z Texto completo
|
| 880 |
8 |
|
|6 505-01/(S
|a GINKGO BILOBA EXTRACTREFERENCES; II -- Pleiotropism and Alzheimer's Disease; 3 -- Primary Prevention of Alzheimer's Disease; GINKGO BILOBA EXTRACTS (₁) ALPHA-SECRETASE (ADAM10); SAPPΑ; GREEN TEA EXTRACTS (₁) ALPHA-SECRETASE (ADAM10); SAPPΑ; OLIVE OIL EXTRACTS (₁) SAPPΑ; RED WINE (CABERNET SAUVIGNON) (₁) ALPHA-SECRETASE; CURCUMINOIDS (₃) BETA-SECRETASE (BACE-1); GINKGO BILOBA EXTRACTS (₃) BETA-SECRETASE; GREEN TEA EXTRACTS (₃) BETA-SECRETASE (BACE-1); CURCUMINOIDS (₃) GAMMA-SECRETASE (PRESENILIN-1); REFERENCES; 4 -- Secondary Prevention of Alzheimer's Disease; CURCUMINOIDS (₃) ABETA AGGREGATION
|
